451 related articles for article (PubMed ID: 22394614)
21. Suppression of replicative senescence by rapamycin in rodent embryonic cells.
Pospelova TV; Leontieva OV; Bykova TV; Zubova SG; Pospelov VA; Blagosklonny MV
Cell Cycle; 2012 Jun; 11(12):2402-7. PubMed ID: 22672902
[TBL] [Abstract][Full Text] [Related]
22. Rapamycin inhibits the secretory phenotype of senescent cells by a Nrf2-independent mechanism.
Wang R; Yu Z; Sunchu B; Shoaf J; Dang I; Zhao S; Caples K; Bradley L; Beaver LM; Ho E; Löhr CV; Perez VI
Aging Cell; 2017 Jun; 16(3):564-574. PubMed ID: 28371119
[TBL] [Abstract][Full Text] [Related]
23. Potential anti-aging agents suppress the level of constitutive mTOR- and DNA damage- signaling.
Halicka HD; Zhao H; Li J; Lee YS; Hsieh TC; Wu JM; Darzynkiewicz Z
Aging (Albany NY); 2012 Dec; 4(12):952-65. PubMed ID: 23363784
[TBL] [Abstract][Full Text] [Related]
24. Gerosuppression by pan-mTOR inhibitors.
Leontieva OV; Blagosklonny MV
Aging (Albany NY); 2016 Dec; 8(12):3535-3551. PubMed ID: 28077803
[TBL] [Abstract][Full Text] [Related]
25. Rapamycin decelerates cellular senescence.
Demidenko ZN; Zubova SG; Bukreeva EI; Pospelov VA; Pospelova TV; Blagosklonny MV
Cell Cycle; 2009 Jun; 8(12):1888-95. PubMed ID: 19471117
[TBL] [Abstract][Full Text] [Related]
26. Weak p53 permits senescence during cell cycle arrest.
Leontieva OV; Gudkov AV; Blagosklonny MV
Cell Cycle; 2010 Nov; 9(21):4323-7. PubMed ID: 21051933
[TBL] [Abstract][Full Text] [Related]
27. Endothelial replicative senescence delayed by the inhibition of MTORC1 signaling involves MicroRNA-107.
Khor ES; Wong PF
Int J Biochem Cell Biol; 2018 Aug; 101():64-73. PubMed ID: 29857052
[TBL] [Abstract][Full Text] [Related]
28. Contact inhibition and high cell density deactivate the mammalian target of rapamycin pathway, thus suppressing the senescence program.
Leontieva OV; Demidenko ZN; Blagosklonny MV
Proc Natl Acad Sci U S A; 2014 Jun; 111(24):8832-7. PubMed ID: 24889617
[TBL] [Abstract][Full Text] [Related]
29. The choice between p53-induced senescence and quiescence is determined in part by the mTOR pathway.
Korotchkina LG; Leontieva OV; Bukreeva EI; Demidenko ZN; Gudkov AV; Blagosklonny MV
Aging (Albany NY); 2010 Jun; 2(6):344-52. PubMed ID: 20606252
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of mammalian target of rapamycin signaling by CCI-779 (temsirolimus) induces growth inhibition and cell cycle arrest in Cashmere goat fetal fibroblasts (Capra hircus).
Wang Z; Liu T; Chen Y; Zhang X; Liu M; Fu H; Liu D
DNA Cell Biol; 2012 Jun; 31(6):1095-9. PubMed ID: 22320865
[TBL] [Abstract][Full Text] [Related]
31. Cooperation between p21 and Akt is required for p53-dependent cellular senescence.
Kim YY; Jee HJ; Um JH; Kim YM; Bae SS; Yun J
Aging Cell; 2017 Oct; 16(5):1094-1103. PubMed ID: 28691365
[TBL] [Abstract][Full Text] [Related]
32. mTOR inhibition acts as an unexpected checkpoint in p53-mediated tumor suppression.
Kon N; Ou Y; Wang SJ; Li H; Rustgi AK; Gu W
Genes Dev; 2021 Jan; 35(1-2):59-64. PubMed ID: 33303641
[TBL] [Abstract][Full Text] [Related]
33. mTOR kinase inhibitor pp242 causes mitophagy terminated by apoptotic cell death in E1A-Ras transformed cells.
Gordeev SA; Bykova TV; Zubova SG; Bystrova OA; Martynova MG; Pospelov VA; Pospelova TV
Oncotarget; 2015 Dec; 6(42):44905-26. PubMed ID: 26636543
[TBL] [Abstract][Full Text] [Related]
34. Opposing p53 and mTOR/AKT promote an in vivo switch from apoptosis to senescence upon telomere shortening in zebrafish.
El Maï M; Marzullo M; de Castro IP; Ferreira MG
Elife; 2020 May; 9():. PubMed ID: 32427102
[TBL] [Abstract][Full Text] [Related]
35. Individual response to mTOR inhibition in delaying replicative senescence of mesenchymal stromal cells.
Antonioli E; Torres N; Ferretti M; Piccinato CA; Sertie AL
PLoS One; 2019; 14(1):e0204784. PubMed ID: 30703123
[TBL] [Abstract][Full Text] [Related]
36. Interaction between mTOR pathway inhibition and autophagy induction attenuates adriamycin-induced vascular smooth muscle cell senescence through decreased expressions of p53/p21/p16.
Sung JY; Lee KY; Kim JR; Choi HC
Exp Gerontol; 2018 Aug; 109():51-58. PubMed ID: 28797827
[TBL] [Abstract][Full Text] [Related]
37. The activation of the p53 pathway by the AMP mimetic AICAR is reduced by inhibitors of the ATM or mTOR kinases.
Zajkowicz A; Rusin M
Mech Ageing Dev; 2011; 132(11-12):543-51. PubMed ID: 21945951
[TBL] [Abstract][Full Text] [Related]
38. Dual mTORC1/C2 inhibitors: gerosuppressors with potential anti-aging effect.
Sousa-Victor P; García-Prat L; Muñoz-Cánoves P
Oncotarget; 2015 Sep; 6(27):23052-4. PubMed ID: 26375366
[TBL] [Abstract][Full Text] [Related]
39. Berberine suppresses gero-conversion from cell cycle arrest to senescence.
Zhao H; Halicka HD; Li J; Darzynkiewicz Z
Aging (Albany NY); 2013 Aug; 5(8):623-36. PubMed ID: 23974852
[TBL] [Abstract][Full Text] [Related]
40. 1,8-Cineole promotes G0/G1 cell cycle arrest and oxidative stress-induced senescence in HepG2 cells and sensitizes cells to anti-senescence drugs.
Rodenak-Kladniew B; Castro A; Stärkel P; Galle M; Crespo R
Life Sci; 2020 Feb; 243():117271. PubMed ID: 31926243
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
